| Host: |
HEK293 cells NA |
| Note: |
STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-SARS-COV-2 Spike S1 (Omicron B.529) Protein-protein was developed from hek293 cells na. For use in research applications. |
| Conjugation: |
Biotin |
| Formulation: |
Lyophilised from 0.2 µm filtered PBS solution pH7.4 |
| Dilution Range: |
Centrifuge vial to ensure maximal product extraction, recommended:20sec, 5K RPM |
| Storage Instruction: |
The lyophilized protein is stable for at least 2 years from date of receipt at-20°C C. |
| Endotoxin: |
Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg). |
| Immunogen: |
DNA sequence encoding SARS-COV-2 Spike S1 (Omicron B.1.1.529) including a C-His-Avi tag was expressed in HEK293 Cells. The recombinant protein was then biotinylated site specific using the AVItag biotinylation technology. |
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
